Overview
News
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Backers
2
HealthCap, Industrifonden
Momentum
0/100
no fresh signals
Last sign of life
this month
a posting or a news item
Backed byfrom the funds' portfolios and accelerator catalogs
HealthCap 
Industrifonden Similar startupsby what they do, their industry and backers
THE CLAUDIN-1 COMPANY Treat cancer and reverse fibrosis We are a clinical-stage biotech company with a mission to treat cancer and reverse…
We partner with top biopharmaceutical companies and research institutions to discover and advance novel therapeutics.
Nuance Pharma are an innovation focused biopharmaceutical company, with both late-stage clinical pipeline and commercial stage asset…
Our mission is to improve the quality of life of patients with myocardial infarction (MI) and heart failure by providing novel…
Discover how Day One Biopharmaceuticals is disrupting the status quo of traditional drug development to bring new medicines to children and…
Manas AI is the AI-native biopharmaceutical company. We combine pioneering AI technology with the first principles of chemistry, physics…
News
Tribune Therapeutics: €37 Million Raised For Treating Root Causes Of Fibrotic Diseases
Tribune Therapeutics - a biotechnology company dedicated to treating the root causes of fibrotic diseases - announced it has raised €37 million in seed and Series A funding to advance a portfolio of therapies targeting central drivers of scar tissue forma
Read more
Report
Financing at Tribune Therapeutics supports targeting CCN protein family to treat fibrosis
Tribune Therapeutics AB has raised €37 million (US$40 million) in seed and series A funding to advance a portfolio of therapies targeting central drivers of scar tissue formation.
Read more
Report